 |  |
| ABX | ||
| 1,320.127 | ||
| 19.4950 | 0.0150% | |
| BISNIS-27 | ||
| 501.246 | ||
| 5.6990 | 0.0115% | |
| DBX | ||
| 2,808.118 | ||
| 61.5990 | 0.0224% | |
| ECONOMIC30 | ||
| 112.463 | ||
| 0.3200 | 0.0029% | |
| ESGQKEHATI | ||
| 119.246 | ||
| 0.3810 | 0.0032% | |
| ESGSKEHATI | ||
| 119.150 | ||
| 0.4060 | 0.0034% | |
| I-GRADE | ||
| 209.718 | ||
| 2.6610 | 0.0129% | |
| AUDRP | ||
| 10,567.170 | ||
| -52.2600 | -0.4921% | |
| EURRP | ||
| 18,901.240 | ||
| -30.5700 | -0.1615% | |
| JPYRP | ||
| 109.733 | ||
| -0.3034 | -0.2757% | |
| SINRP | ||
| 12,684.540 | ||
| 1.3500 | 0.0106% | |
| USDRP | ||
| 16,325.000 | ||
| 55.0000 | 0.3380% | |
Penelitian terhadap vaksin nasional COVID-19, Vaksin Merah Putih, terus berlanjut, salah satunya oleh tim peneliti Universitas Airlangga bersama PT Biotis Pharmaceutical Indonesia. Penelitian vaksin telah memasuki uji praklinis tahap II.
